Diversify Wealth Management LLC increased its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 118.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,844 shares of the semiconductor company’s stock after buying an additional 2,631 shares during the quarter. Diversify Wealth Management LLC’s holdings in Synopsys were worth $1,921,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Sankala Group LLC bought a new position in Synopsys during the fourth quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys in the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys during the 4th quarter worth about $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys during the 4th quarter valued at about $32,000. Finally, Osbon Capital Management LLC bought a new position in Synopsys during the 4th quarter valued at about $34,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several brokerages have issued reports on SNPS. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. BNP Paribas Exane upped their target price on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Stifel Nicolaus raised their price target on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $570.06.
Synopsys Trading Down 1.8%
Shares of SNPS opened at $425.90 on Wednesday. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73. The company has a 50-day moving average of $475.30 and a 200 day moving average of $459.92. The firm has a market capitalization of $81.55 billion, a price-to-earnings ratio of 98.59, a PEG ratio of 2.55 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.
Insider Buying and Selling
In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
